drug · Product Intelligence

Propofol
Pipeline Intelligence

Propofol: 6 indexed trials, 6 sponsors; 0 linked Orange Book patents and 13 FDA-linked events where matched.

⚗
6Indexed trials
▦
6Sponsors
⌁
0Orange Book patent links
◎
13FDA-linked events

Development evidence

NCT01126957University of Missouri-Columbia · other_neurologyNA
NCT02256319Clinica Universidad de Navarra, Universidad de Navarra · parkinsonsPHASE4
NCT03193710Guizhi Du · out_of_scopeUNKNOWN
NCT03326960Shanghai 10th People's Hospital · other_psychiatryUNKNOWN
NCT03513757Medical College of Wisconsin · epilepsyPHASE4
NCT05266560First Affiliated Hospital of Chongqing Medical University · depressionEARLY_PHASE1

FDA / patent evidence

Orange Book match found; no listed patent relation was retained for this product match.

Regulatory context

FDA_APPROVALPROPOFOL · 2026-07-14
FDA_APPROVALPROPOFOL · 2025-12-02
FDA_APPROVALPROPOFOL · 2024-08-15
FDA_APPROVALPROPOFOL · 2024-06-20
FDA_APPROVALPROPOFOL · 2021-10-12
FDA_APPROVALPROPOFOL · 2020-09-16
FDA_APPROVALPROPOFOL · 2018-11-15
FDA_APPROVALPROPOFOL · 2015-12-22
FDA_APPROVALPROPOFOL · 2006-03-17
FDA_APPROVALPROPOFOL · 2005-04-19
FDA_APPROVALPROPOFOL · 2000-09-19
FDA_APPROVALPROPOFOL · 1999-01-04

FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.